In many cases the tumor suppressor activity of RBL1 or RBL2 is only revealed in the absence of RB1. There is less evidence indicating loss of RBL1 or RBL2 potentiates cancer initiation or progression in contexts where RB1 remains intact. Here, RB1 is linked to neoplasm.